Clinical trials
Active, not recruiting Breast Neoplasms trials in Greece
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 7 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 33 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 6 |
| Hoffmann-La Roche | 4 |
| AstraZeneca | 3 |
| Hellenic Cooperative Oncology Group | 3 |
| Novartis Pharmaceuticals | 2 |
| Pfizer | 2 |
| University Hospital, Basel, Switzerland | 2 |
| Amgen | 1 |
| Celcuity Inc | 1 |
| ETOP IBCSG Partners Foundation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 33 |
| Neoplasm Metastasis | 4 |
| Triple Negative Breast Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Lymphatic Metastasis | 1 |
| Ovarian Neoplasms | 1 |
| Prostatic Neoplasms | 1 |
| Recurrence | 1 |
| Unilateral Breast Neoplasms | 1 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.